SPOTLIGHT -
CDC recommends nirsevimab immunization to prevent RSV in infants
The federal agency says infants of a certain age should receive this monoclonal antibody to protect against the virus.
Changing the RSV prevention landscape
From a virus that had no treatment options, to one that may be prevented in two different modalities, clinicians are hoping to see a reduction in respiratory syncytial virus (RSV) incidence rates, starting this fall.
MRNA vaccines efficacious against Omicron infections in children younger than 12
In a large observational study, significant information was obtained about protection against acute infection and disease severity in this age group.
FDA accepts BLA for Pfizer maternal RSV vaccine
The federal agency set a Prescription Drug User Fee Act (PDUFA) action date of August 2023.
CDC updates vaccination schedule for children and adolescents, includes COVID-19 vaccine
The 2023 changes include vaccines for influenza, pneumococcal disease, measles, mumps, and rubella (MMR) and COVID-19.
